Skip to main content

US grocery prices rose in April, but gas spikes weren’t the only reason

Americans paid more for their groceries last month, but high gasoline prices resulting from the Iran war were only one of the reasons why.

Prices for food eaten at home rose 2.9% in April compared to the same month a year earlier, according to government figures released Tuesday. That was the highest year-over-year inflation rate for the category since August 2023.

Prices at restaurants, fast-food chains and other places to get prepared meals also increased, putting overall food prices up 3.2% in the last year, the Labor Department’s consumer price index showed.

Fuel prices have soared while the Iran war prevents cargo ships from passing through the Strait of Hormuz, a vital corridor for global oil supplies. Diesel fuel powers fishing boats, tractors and the trucks that ship 83% of U.S. agricultural products. As of Tuesday, the average price per gallon was up 61% from a year ago, according to AAA.

The meat, produce and dry goods vendors that supply Sparrow Market, a small independent grocer in Ann Arbor, Michigan, all added fuel surcharges to their deliveries in recent weeks, owner Raymond Campise said. Wholesale prices for meat, produce and some other products also have gone up, he said.

“For independent markets operating on narrow margins, even small increases can have a major impact,” Campise said.

The full impact of rising energy costs on food likely has not hit retail grocery prices yet in the U.S., according to Purdue University economists Ken Foster and Bernhard Dalheimer. Higher costs to produce, process, store and transport food can take three to six months to show up on supermarket shelves, where prices typically fall slowly once increased, they said.

“Most of what we’re seeing now in the food price chain probably predates the conflict,” Foster, a professor of agricultural economics, said. “We’re cautiously waiting to see what the June numbers and the May numbers might show as they come out in terms of … the extent to which energy shocks in the Strait of Hormuz and shipping blockades and so forth are going to impact food prices.”

The consumer price index measures changes in what people in U.S. cities paid at retail stores for meat, bread, milk, produce and other grocery staples. Over the last 20 years, grocery prices increased an average of 2.6%, according to the U.S. Department of Agriculture.

Prices for perishable and refrigerated products tend to increase faster than prices for packaged goods when energy is an issue. Consumers paid 6.5% more for fresh fruit and vegetables in U.S. cities last month than they did in April 2025, and 8.8% more for meat, the Labor Department reported.

But U.S. trade policies and extreme weather also have weighed on U.S. food prices in the last year. In July 2025, the Trump administration imposed a 17% duty on fresh tomatoes imported from Mexico; consumer prices rose 40% in the 12 months before April.

Dry weather in the Western U.S. has been one of many factors pushing up beef prices, which in April were 15% higher year-over-year. Coffee prices were up 18.5%, partly due to drought and other weather conditions that have hurt global coffee production in recent years.

“Today’s CPI showed that food prices have been rising 3.2 percent in the past year, but the story behind that number is more complicated than just an energy shock,” said Dalheimer, an assistant professor of macroeconomics and trade in Purdue’s Department of Agricultural Economics.

Prices for some foods remained more or less flat or declined over 12 months. Milk and chicken dipped slightly. Butter cost 5.8% less in April than it did a year earlier. Egg prices fell 39% as farmers rebuilt flocks that were decimated by an ongoing bird flu outbreak.

Food prices and broader inflation are likely to feature prominently in November’s midterm elections. During his 2024 campaign, President Donald Trump often cited the prices of bacon, cereal, crackers and other groceries as reasons why voters should return him to the White House.

Some food producers say they’re struggling now because of higher fuel costs. The Southern Shrimp Alliance, which represents shrimpers in eight states, said some boats haven’t left the dock this spring because they can’t catch enough shrimp to compensate for the cost of diesel.

Fuel typically makes up 30% to 50% of the costs for U.S. shrimpers, but because they supply only 6% of the shrimp that Americans consume, they have limited ability to raise prices or add surcharges for fuel, the organization said.

Higher fuel prices may also be impacting food costs in other ways. Part of April’s 5% annual increase in prices for nonalcoholic beverages may be due to the petroleum derivative that goes into making plastic bottles, Foster said.

“It’s possible some of that’s starting to seep down the supply chain and get into those prices,” he said.

Over the next year or more, Americans could also see higher food prices due to spiking fertilizer costs, since around 30% of the world’s fertilizer travels through the Strait of Hormuz.

Fertilizer costs are less of an issue for U.S. farmers this year, since many already had fertilizer supplies in place before the war began, according to Foster. But the effects could become more noticeable next year if the war drags on, he said.

“I expect the Iran conflict to impact the coming years’ food prices through a couple of channels. One, the energy costs and transportation handling. The other would be through packaging costs,” Foster said. “If the conflict were to last longer, then we might see more coming online as fertilizer prices start to impact longer-term planting decisions and cropping decisions.”

When you have advanced prostate cancer: What living with the disease looks like

(CNN) — “How long do I have to live ?”When I tell a patient he has prostate cancer, this is usually what he asks me first.With early-stage or low-grade prostate cancer, I can offer strong reassurance: Your life expectancy is good — expect a five-year relative survival rate of greater than 99% with treatment. Simply put, most men will not die from low-grade prostate cancer.However, once the cancer has spread outside the prostate to the bones and other organs the answer becomes more difficult. Treatment has changed dramatically over the past decade for advanced prostate cancer. New drugs, better imaging and the earlier use of combined therapies are helping men live longer.In a video released July 15, former President Joe Biden gave an update on his prostate cancer, saying he was receiving treatments that have been going well. In May 2025, Biden officially announced that he had an aggressive form of prostate cancer that had spread to his bones. Since then, based on official updates, he has continued hormone therapy, completed a course of radiation and maintained a public presence.His diagnosis brought renewed attention to prostate cancer screening and treatment. Now, more than a year later, his cancer journey offers an opportunity to examine what has changed in the treatment of advanced prostate cancer — and the hope these offer men living with the disease.I recently saw a patient who was diagnosed three years ago with cancer that had already spread to multiple areas in his bones. Since then, he has taken cruises, traveled with his family and spent weekends babysitting his grandchildren.He gets tired and cannot garden the way he once did. But he is still alive and considers every day a blessing. His experience, and what we see with Biden, shows what living with metastatic prostate cancer can look like today.Understanding survival ratesIf they haven’t asked their doctor already, many patients go online and find five-year survival rates, but every number they may find online comes with a huge asterisk.The American Cancer Society reports five-year relative survival of greater than 99% when prostate cancer is found in or near the prostate. The figure drops to 38% when it has reached distant parts of the body.But that number is based on large groups of men treated years ago. It does not fully reflect the impact of newer treatments — or account for an individual man’s age, overall health and response to therapy.Survival statistics describe groups of patients but do not predict what will happen to one person. That is why the 38% figure cannot tell us how long Biden — or any individual patient — will live. These patients’ outlook depends on details of their cancer and how they are responding to treatments.It’s treated more aggressively nowA man diagnosed with metastatic prostate cancer a decade ago and a man diagnosed today would not receive the same treatment. The thinking now is to use our best treatments early instead of holding back.For years, doctors began with hormone therapy — usually injections that lower testosterone — and saved other treatments until the cancer stopped responding.Today, those injections are often combined from the start with a newer hormone-blocking drug and/or chemotherapy. These combinations have helped men live longer and are one of the biggest shifts of the past decade.What Biden’s diagnosis told usThere are three details about Biden’s cancer that help doctors like me understand how aggressive it is and how to manage it effectively. Official statements highlighted that his cancer had a Gleason score of 9. The cancer had spread to his bones, and it was labeled as hormone-sensitive.The Gleason score is assigned after a pathologist examines biopsy samples. Scores typically range from 6 to 10, with higher numbers indicating more aggressive cancer. A score of 9 falls into the most aggressive category. However, the score alone cannot tell us whether the cancer has spread outside the prostate.When prostate cancer spreads, the most common destination is the bones — particularly the spine, pelvis and ribs. It can also reach organs such as the lungs or liver. Once it has reached distant parts of the body, it is generally not curable, but treatment can put a brake on it for years.Prostate cancer can also be hormone-sensitive or hormone-resistant. Because it typically relies on testosterone to grow, lowering the hormone or blocking its effects can help control the cancer. Hormone-sensitive means it still responds to these treatments.Over time, most advanced or metastatic prostate cancers find ways to grow despite low testosterone levels, which mean they are now hormone-resistant. Lowering testosterone alone is no longer enough to control the cancer, so doctors have to turn to additional therapies.Knowing if the cancer has spreadThe most sensitive imaging test available today is a PSMA PET scan. It uses a radioactive tracer that seeks out a protein found on the surface of prostate cancer cells. Areas containing cancer may appear as bright spots, helping identify where the cancer has spread. The American Urological Association supports using this imaging test to determine whether high-risk prostate cancer has spread and to help establish its stage.A traditional bone scan, used for decades, highlights areas where bone is reacting to injury or disease. It remains an alternative imaging option, but PSMA PET is increasingly replacing its use.What areas light up and where matter when deciding on treatments. A single spot in the spine and cancer that has spread to the liver are both called stage 4, but they are not the same disease and may not be treated the same way.Doctors also consider how much cancer has spread. We label it as “low-volume” disease when the cancer has reached a limited number of areas. High volume is when the spread is more widespread or has reached other organs such as the liver or lungs.Both require treatment that works throughout the body. Treatment for metastatic disease generally includes therapy that works throughout the body. For men with low-volume disease, adding radiation to the prostate may also help them live longer.Biden has completed a course of radiation, but his team has not disclosed what area was treated or enough detail to determine whether his cancer would be considered low- or high-volume.Treatment has become more preciseBeyond starting more treatments earlier, doctors can increasingly tailor therapy to the biology of an individual man’s cancer. We can now test both the tumor and a patient’s own DNA for mutations that help guide treatment.Roughly 1 in 10 men with metastatic prostate cancer carries an inherited mutation affecting the body’s ability to repair DNA. The best known are BRCA1 and BRCA2, the same genes linked to some breast and ovarian cancers.Certain mutations found in the tumor or inherited DNA may make targeted drugs called PARP inhibitors an option. If a mutation is inherited, it also gives family members information they can act on through genetic counseling, testing and earlier screening.Another advance is radioligand therapy. If a scan shows that cancer cells carry a protein called PSMA, doctors can attach radiation to a molecule that seeks out that protein. Delivered through an IV, it targets cancer cells throughout the body. This approach was expanded last year to more men whose cancer had become hormone resistant.Living longer can come with costsEvery treatment can cause side effects. With hormone therapy, one of the first is often hot flashes, similar to what women experience during menopause. These are not dangerous, but they can affect a man’s quality of life.Fatigue is also common. Testosterone helps maintain muscle, so lowering it can reduce strength and energy. Regular walking and resistance training can help preserve muscle and reduce fatigue.The side effect almost no one talks about is loss of sex drive or low libido. At diagnosis, most men are thinking about staying alive, not their libido. But months later, it often matters. It is worth discussing with your care team and your partner rather than assuming it is simply the price of treatment.The side effect I worry about most is weaker bones. Low testosterone reduces bone density, while cancer deposits can weaken the bone’s structure. Follow-up care should include exercise, a bone-density scan, and ensuring adequate levels of calcium and vitamin D. For men with hormone-resistant cancer that has spread to bone, bone-protecting drugs can reduce the risk of fractures and other complications.New or worsening back pain, especially with leg weakness, numbness or trouble controlling the bladder or bowels? These could mean the cancer is pressing on the spinal cord. It is a true medical emergency that requires immediate attention.Cancer care requires a team approachIdeally, several doctors work together to coordinate a patient’s care. The urologist is often the starting point. A medical oncologist manages treatments that work throughout the body, while a radiation oncologist targets specific areas, whether that is the prostate itself or a painful bone lesion. The primary care doctor helps protect the patient’s heart and bones and looks after the person’s overall health.A man’s age, other medical conditions, ability to tolerate side effects and goals for treatment all shape treatment plans. Two men with nearly identical test results may be offered — or choose — different paths based on their health and priorities.Good communication among doctors is essential, but gaps can happen. Being your own advocate means knowing who is on your care team, asking questions and understanding your options.I also recommend bringing someone you trust to important visits for support and to take notes and help you remember what was discussed.More treatments, better testing offer hopeFor men worried about prostate cancer, talk with your health care provider about the benefits and risks of PSA testing. Black men and those with a strong family history should begin that conversation in their 40s. New urinary symptoms are often not cancer, but they still deserve attention, as does blood in the urine or semen, unexplained weight loss and/or persistent back or bone pain.For men living with advanced prostate cancer, there is reason for hope. There are more treatments and better testing than there were a decade ago, and good care pays attention to how a man feels, not just to what his scans show.The-CNN-Wire™ & © 2026 Cable News Network, Inc., a Warner Bros. Discovery Company. All rights reserved.
Read Next Story